The medication, also approved in the United States, is the first approved monoclonal antibody that specifically blocks the signaling of interleukin (IL)-31.
As everyone knows, scratching at chronically itchy skin only makes the problem worse. A new device is claimed to help stop ...
The following is a summary of “Impact of COVID-19 disease and vaccination on dermatological immune-mediated inflammatory ...